Vicki L. Sato, Director at Vir Biotechnology, Inc. (VIR), sold 22,000 shares at $4.99 ($110K) on 2025-08-01, disclosed to the SEC on 2025-08-04.
Scheduled sale ($110k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VIR | SELL | 2026-03-03 | $416K | — | Filing → |
| VIR | SELL | 2026-02-26 | $825K | — | Filing → |
| VIR | SELL | 2026-02-03 | $170K | — | Filing → |